$JAGX JAGX has an FDA approved organic treatment (Crofelemer/Mytesi) that is being used to treat HIV with the potential to treat multiple health issues including COVID-19, cancer, cholera, and psychological disorders, increasing sales revenue quarter over quarter. Jaguar Health, Inc. and the Company's wholly-owned subsidiary, Napo Pharmaceuticals, Inc. doing a merger in Europe and has conducted intellectual property filings in support of the development of crofelemer for the potential indication of addressing inflammatory diarrhea, including specifically in a long-hauler post-COVID recovery situation which is estimated to affect 15% (or 100 million) of the world population. THIS IS THE REAL DEAL...NOT HYPE OR SPECULATION !
  • 3
3 Likes